How can nanotechnology help the fight against breast cancer? Elisabetta Avitabile, Davide Bedognetti, Gianni Ciofani, Alberto Bianco and Lucia Gemma Delogu Nanoscale  

How can nanotechnology help the fight against breast cancer? Elisabetta Avitabile, Davide Bedognetti, Gianni Ciofani, Alberto Bianco and Lucia Gemma Delogu Nanoscale

BMP9 counteracts the tumorigenic and pro-angiogenic potential of glioblastoma Elena Porcù, Francesca Maule, Daniele Boso, Elena Rampazzo, Vito Barbieri, Gaia Zuccolotto, Antonio Rosato, Chiara Frasson, Giampietro Viola, Allesandro Della Puppa, Giuseppe Basso, Luca Persano Official journal of the Cell Death Differentiation Association

Somatic mutations in specific and connected sub-pathways are associated to short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease Maria Rosaria Esposito, Andrea Binatti, Marcella Pantile, Alessandro Coppe, Katia Mazzocco, Luca Longo, Mario Capasso, Vito Alessandro Lasorsa, Roberto Luksch, Stefania Bortoluzzi, Gian Paolo Tonini International Journal of Cancer

Could the interaction between LMX1B and PAX2 influence the severity of renal symptoms? Negrisolo S, Carraro A, Fregonese G, Benetti E, Schaefer F, Alberti M, Melchionda S, Fischetto R, Giordano M, Murer L European Society of Human Genetics 2018

Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial Gianni Bisogno, Meriel Jenney, Christophe Bergeron, Soledad Gallego Melcón, Andrea Ferrari, Odile Oberlin, Modesto Carli, Michael Stevens, Anna Kelsey, Angela De Paoli, Mark N Gaze, Helene Martelli, Christine Devalck, Johannes H Merks, Myriam Ben-Arush, Heidi Glosli, Julia Chisholm, Daniel Orbach, Veronique Minard-Colin, Gian Luca De Salvo European paediatric Soft tissue sarcoma Study Group